" /> Skip to main content
CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Alembic Pharma gets USFDA final approval for Olopatadine eye drops

Source By

Dion Global

05 Nov 2026

Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride Ophthalmic Solution USP.

The product is therapeutically equivalent to Alcon Laboratories' reference drug, Pataday Once Daily Relief 0.7%.

The eye drops are indicated for temporary relief from itchy eyes caused by pollen, ragweed, grass, animal hair and dander, the company said in a regulatory filing.